Green Street Investors LLC lifted its position in shares of HCP, Inc. (NYSE:HCP) by 2.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 399,100 shares of the real estate investment trust’s stock after purchasing an additional 8,000 shares during the period. HCP comprises about 8.3% of Green Street Investors LLC’s holdings, making the stock its 2nd largest position. Green Street Investors LLC owned 0.08% of HCP worth $14,220,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Nuveen Asset Management LLC grew its holdings in shares of HCP by 196.6% during the second quarter. Nuveen Asset Management LLC now owns 8,643,947 shares of the real estate investment trust’s stock worth $276,433,000 after buying an additional 5,729,136 shares during the last quarter. Unigestion Holding SA grew its holdings in shares of HCP by 1,639.7% during the second quarter. Unigestion Holding SA now owns 2,016,300 shares of the real estate investment trust’s stock worth $64,481,000 after buying an additional 1,900,400 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of HCP by 35.4% during the second quarter. Bank of New York Mellon Corp now owns 6,767,646 shares of the real estate investment trust’s stock worth $216,429,000 after buying an additional 1,769,116 shares during the last quarter. Commonwealth Bank of Australia grew its holdings in shares of HCP by 2,313.5% during the second quarter. Commonwealth Bank of Australia now owns 1,570,166 shares of the real estate investment trust’s stock worth $50,205,000 after buying an additional 1,505,109 shares during the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC grew its holdings in shares of HCP by 11.3% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,177,081 shares of the real estate investment trust’s stock worth $453,383,000 after buying an additional 1,441,636 shares during the last quarter. Institutional investors and hedge funds own 95.80% of the company’s stock.
Shares of HCP stock traded down $0.89 during midday trading on Friday, reaching $33.64. 4,003,528 shares of the company traded hands, compared to its average volume of 2,801,829. The firm’s 50 day simple moving average is $36.24 and its two-hundred day simple moving average is $33.42. HCP, Inc. has a 1-year low of $26.58 and a 1-year high of $37.93. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.81 and a quick ratio of 0.81. The firm has a market cap of $17.57 billion, a PE ratio of 18.48, a price-to-earnings-growth ratio of 6.81 and a beta of 0.22.
HCP (NYSE:HCP) last posted its quarterly earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.52). HCP had a net margin of 43.66% and a return on equity of 12.78%. The company had revenue of $538.00 million for the quarter, compared to analyst estimates of $503.65 million. During the same quarter in the previous year, the business posted $0.44 earnings per share. HCP’s revenue was up 18.0% on a year-over-year basis. As a group, research analysts anticipate that HCP, Inc. will post 1.75 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be given a dividend of $0.37 per share. The ex-dividend date is Friday, November 1st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.40%. HCP’s payout ratio is 81.32%.
In other news, COO Thomas Klaritch sold 35,014 shares of HCP stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total transaction of $1,261,204.28. Following the completion of the sale, the chief operating officer now directly owns 230,529 shares in the company, valued at approximately $8,303,654.58. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.13% of the stock is currently owned by company insiders.
A number of equities analysts recently issued reports on the company. ValuEngine lowered HCP from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. raised HCP from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $35.00 to $38.00 in a report on Tuesday, October 8th. Scotiabank set a $38.00 price target on HCP and gave the stock a “buy” rating in a report on Monday, September 30th. TheStreet raised HCP from a “c+” rating to a “b-” rating in a report on Friday, August 2nd. Finally, KeyCorp raised their price target on HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. HCP has an average rating of “Buy” and an average price target of $36.78.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: Trading Strategy
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.